Sentinel lymph node biopsy or nodal observation in melanoma: A prospective study of patient choices

Dermatologic Surgery

Volumn 37, Issue 2, 2011, Pages 199-206

  Grange, Florent ^a   Maubec, Eve ^b   Barbe, Coralie ^c   Kassouma, Jamal ^d   Vitry, Fabien ^c   Johanet, Hubert ^b   Granel Brocard, Florence ^e   Boitier, Francoise ^f   Girod, Angelique ^g   Couturaud, Benoit ^g   Saez, Pierre ^b   Albert, Sebastien ^b   Le Clainche, Annick ^c   Descamps, Vincent ^b   Avril, Marie Francoise ^f  

^a SERVICE DE DERMATOLOGIE   (France)

^b BICHAT HOSPITAL   (France)

^c Centre de Recherche   (France)

^d HÔPITAL MAISON BLANCHE   (France)

^e SERVICE DE DERMATOLOGIE   (France)

^f Institut Cochin   (France)

^g INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; FEMALE; HEAD AND NECK MELANOMA; HUMAN; INFORMED CONSENT; INTERPERSONAL COMMUNICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL PRACTICE; MEDICAL SPECIALIST; MELANOMA; NODAL OBSERVATION; OBSERVATIONAL METHOD; PATIENT COUNSELING; PATIENT DECISION MAKING; PATIENT PREFERENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCHOOL CHILD; SENTINEL LYMPH NODE BIOPSY; VERBAL COMMUNICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DIRECTIVE COUNSELING; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM STAGING; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT EDUCATION AS TOPIC; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 79951946379     PISSN: 10760512     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.2010.01855.x     Document Type: Article

References (25)

1. Dummer R, Panizzon R, Bloch PH, Burg G., Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology 2005; 210: 39-44. (Pubitemid 39656718)
2. Garbe C, Hauschild A, Volkenandt M, et al,. Evidence and interdisciplinary consensus-based German guidelines: surgical treatment and radiotherapy of melanoma. Melanoma Res 2008; 18: 61-7.
3. Saiag P, Bosquet L, Guillot B, et al,. Management of adult patients with cutaneous melanoma without distant metastasis. 2005 update of the French standards, options and recommendations guidelines. Summary report. Eur J Dermatol 2007; 17: 325-31. (Pubitemid 47051549)
4. Coit DG, Andtbacka R, Bichakjian CK, et al,. NCCN clinical practice guidelines in oncology: melanoma. J Nat Compr Canc Netw 2009; 7: 250-75.
5. Grange F, Vitry F, Granel-Brocard F, et al,. Variations in management of stage I to III cutaneous melanoma: a population-based study of clinical practices in France. Arch Dermatol 2008; 144: 629-36.
6. Dummer R., How melanoma is treated in real life. Arch Dermatol 2008; 144: 664-5. (Pubitemid 351724430)
7. Garreau JR, Nelson J, Cook D, et al,. Geographic variation in sentinel node adaptation by practicing surgeons in Oregon. Am J Surg 2005; 189: 619-20.
8. Cormier JN, Xing Y, Ding M, et al,. Population-based assessment of surgical treatment trends for patients with melanoma in the era of sentinel lymph node biopsy. J Clin Oncol 2005; 25: 6054-62.
9. Lens MB, Dawes M, Newton-Bishop JA, Goodacre T., Management of regional lymph nodes in patients with malignant melanoma: questionnaire survey of UK current practice. Br J Plast Surg 2002; 55: 372.
10. Bilimoria KY, Balch CM, Wayne JD, et al,. Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. J Clin Oncol 2009; 27: 1857-63.
11. Cochran AJ, Balda BR, Starz H, et al,. The Augsburg Consensus. Techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer 2000; 89: 236-41. (Pubitemid 30489868)
12. Morton DL, Thompson JF, Cochran AJ, et al,. Sentinel-node biopsy or nodal observation in melanoma. N Eng J Med 2006; 355: 1307-17. (Pubitemid 44465459)
13. Grob JJ, Dreno B, de la Salmonière P, et al,. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French cooperative group on melanoma. Lancet 1998; 351: 1905-10. (Pubitemid 28297445)
14. Balch CM, Cascinelli N., Sentinel-node biopsy in melanoma. N Eng J Med 2006; 13: 1370-1. (Pubitemid 44465466)
15. Thomas JM., Sentinel-node biopsy in melanoma. New Eng J Med 2007; 356: 418.
16. A'Hern RP., Sentinel-node biopsy in melanoma. New Eng J Med 2007; 356: 419.
17. Lipsker D., Sentinel-node biopsy in melanoma. New Eng J Med 2007; 356: 419.
18. Morton DL, Cochran AJ, Thompson JF., Authors' response to a letter to the editor: sentinel-node biopsy for early-stage melanoma. Ann Surg 2007; 245: 828-9.
19. Thomas JM., Concerns relating to the conduct and statistical analysis of the Multicenter Selective Lymphadenopathy Trial (MSLT-1) in patients with melanoma. J Plast Reconstr Aesthet Surg 2009; 62: 442-6.
20. Balch CM, Morton DL, Gershenwald JE, et al,. Sentinel node biopsy and standard of care in melanoma. J Am Acad Dermatol 2009; 60: 872-5.
21. Nowecki ZI, Rutkowski P, Michej W., The survival benefit of patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with primary lesions Breslow thickness greater 1.0 mm and less than or equal to 4 mm (pT2-pT3). Ann Surg Oncol 2008; 15: 2223-34.
22. Kruit WH., Dutch Melanoma Working Group. Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications. Ned Tijdschr Geneeskd 2008; 152: 574-6.
23. de Wilt JH, van Akkooi AC, Verhoef C, Eggermont AM., Detection of melanoma micrometastases in sentinel nodes-the cons. Surg Oncol 2008; 17: 175-81.
24. Tanis PJ, Nieweg OE, ven den Brekel MW, Balm AJ., Dilemma of clinically node-negative head and neck melanoma: outcome of "watch and wait" policy, elective lymph node dissection, and sentinel node biopsy. A systematic review. Head Neck 2008; 30: 380-9.
25. Samphao S, Eremin JM, El-Sheemy M, Eremin O., Management of the axilla in women with breast cancer: current clinical practice and a new selective targeted approach. Ann Sur Oncol 2008; 15: 1282-96.